263 related articles for article (PubMed ID: 37070985)
21. Antibiotic Potentiation in Multidrug-Resistant Gram-Negative Pathogenic Bacteria by a Synthetic Peptidomimetic.
Mood EH; Goltermann L; Brolin C; Cavaco LM; Nejad AJ; Yavari N; Frederiksen N; Franzyk H; Nielsen PE
ACS Infect Dis; 2021 Aug; 7(8):2152-2163. PubMed ID: 34227804
[TBL] [Abstract][Full Text] [Related]
22. Predictive factors for multidrug-resistant gram-negative bacteria among hospitalised patients with complicated urinary tract infections.
Gomila A; Shaw E; Carratalà J; Leibovici L; Tebé C; Wiegand I; Vallejo-Torres L; Vigo JM; Morris S; Stoddart M; Grier S; Vank C; Cuperus N; Van den Heuvel L; Eliakim-Raz N; Vuong C; MacGowan A; Addy I; Pujol M;
Antimicrob Resist Infect Control; 2018; 7():111. PubMed ID: 30220999
[TBL] [Abstract][Full Text] [Related]
23. Bismuth Drugs Reverse Tet(X)-Conferred Tigecycline Resistance in Gram-Negative Bacteria.
Deng T; Jia Y; Tong Z; Shi J; Wang Z; Liu Y
Microbiol Spectr; 2022 Feb; 10(1):e0157821. PubMed ID: 35138168
[TBL] [Abstract][Full Text] [Related]
24. Resistance in nonfermenting gram-negative bacteria: multidrug resistance to the maximum.
McGowan JE
Am J Med; 2006 Jun; 119(6 Suppl 1):S29-36; discussion S62-70. PubMed ID: 16735148
[TBL] [Abstract][Full Text] [Related]
25. Staphylococcal Bacterial Persister Cells, Biofilms, and Intracellular Infection Are Disrupted by JD1, a Membrane-Damaging Small Molecule.
Dombach JL; Quintana JLJ; Detweiler CS
mBio; 2021 Oct; 12(5):e0180121. PubMed ID: 34634935
[TBL] [Abstract][Full Text] [Related]
26. Screening and Potential of the Incidence of Resistance Transfer Among the Multidrug and Heavy Metal Resistant Gram-Negative Isolates from Hospital Effluents of Northern India.
Alam M; Imran M
Recent Pat Antiinfect Drug Discov; 2018; 13(2):164-179. PubMed ID: 29984669
[TBL] [Abstract][Full Text] [Related]
27. Synergy between Active Efflux and Outer Membrane Diffusion Defines Rules of Antibiotic Permeation into Gram-Negative Bacteria.
Krishnamoorthy G; Leus IV; Weeks JW; Wolloscheck D; Rybenkov VV; Zgurskaya HI
mBio; 2017 Oct; 8(5):. PubMed ID: 29089426
[TBL] [Abstract][Full Text] [Related]
28. Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli.
Zhanel GG; Golden AR; Zelenitsky S; Wiebe K; Lawrence CK; Adam HJ; Idowu T; Domalaon R; Schweizer F; Zhanel MA; Lagacé-Wiens PRS; Walkty AJ; Noreddin A; Lynch Iii JP; Karlowsky JA
Drugs; 2019 Feb; 79(3):271-289. PubMed ID: 30712199
[TBL] [Abstract][Full Text] [Related]
29. Optimized arylomycins are a new class of Gram-negative antibiotics.
Smith PA; Koehler MFT; Girgis HS; Yan D; Chen Y; Chen Y; Crawford JJ; Durk MR; Higuchi RI; Kang J; Murray J; Paraselli P; Park S; Phung W; Quinn JG; Roberts TC; Rougé L; Schwarz JB; Skippington E; Wai J; Xu M; Yu Z; Zhang H; Tan MW; Heise CE
Nature; 2018 Sep; 561(7722):189-194. PubMed ID: 30209367
[TBL] [Abstract][Full Text] [Related]
30. Adjunctive transferrin to reduce the emergence of antibiotic resistance in Gram-negative bacteria.
Luna BM; Ershova K; Yan J; Ulhaq A; Nielsen TB; Hsieh S; Pantapalangkoor P; Vanscoy B; Ambrose P; Rudin S; Hujer K; Bonomo RA; Actis L; Skaar EP; Spellberg B
J Antimicrob Chemother; 2019 Sep; 74(9):2631-2639. PubMed ID: 31170282
[TBL] [Abstract][Full Text] [Related]
31. Combination antibiotic therapy for empiric and definitive treatment of gram-negative infections: insights from the Society of Infectious Diseases Pharmacists.
Boyd N; Nailor MD
Pharmacotherapy; 2011 Nov; 31(11):1073-84. PubMed ID: 22026395
[TBL] [Abstract][Full Text] [Related]
32. Development of Novel Immunoprophylactic Agents against Multidrug-Resistant Gram-Negative Bacterial Infections.
Lovey A; Krel M; Borchardt A; Brady T; Cole JN; Do QQ; Fortier J; Hough G; Jiang W; Noncovich A; Tari L; Zhao Q; Balkovec JM; Zhao Y; Perlin DS
Antimicrob Agents Chemother; 2021 Oct; 65(11):e0098521. PubMed ID: 34370589
[TBL] [Abstract][Full Text] [Related]
33. Synergistic effects of baicalein with ciprofloxacin against NorA over-expressed methicillin-resistant Staphylococcus aureus (MRSA) and inhibition of MRSA pyruvate kinase.
Chan BC; Ip M; Lau CB; Lui SL; Jolivalt C; Ganem-Elbaz C; Litaudon M; Reiner NE; Gong H; See RH; Fung KP; Leung PC
J Ethnopharmacol; 2011 Sep; 137(1):767-73. PubMed ID: 21782012
[TBL] [Abstract][Full Text] [Related]
34. Choice of therapeutic interventions and outcomes for the treatment of infections caused by multidrug-resistant gram-negative pathogens: a systematic review.
Nørgaard SM; Jensen CS; Aalestrup J; Vandenbroucke-Grauls CMJE; de Boer MGJ; Pedersen AB
Antimicrob Resist Infect Control; 2019; 8():170. PubMed ID: 31709047
[TBL] [Abstract][Full Text] [Related]
35. Multidrug-Resistant Gram-Negative Bacteria and Extended-Spectrum β-Lactamase-Producing Klebsiella pneumoniae from the Poultry Farm Environment.
Veloo Y; Thahir SSA; Rajendiran S; Hock LK; Ahmad N; Muthu V; Shaharudin R
Microbiol Spectr; 2022 Jun; 10(3):e0269421. PubMed ID: 35467407
[TBL] [Abstract][Full Text] [Related]
36. Potential strategies for the eradication of multidrug-resistant Gram-negative bacterial infections.
Huwaitat R; McCloskey AP; Gilmore BF; Laverty G
Future Microbiol; 2016 Jul; 11():955-72. PubMed ID: 27357521
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and
Cruz-López F; Martínez-Meléndez A; Morfin-Otero R; Rodriguez-Noriega E; Maldonado-Garza HJ; Garza-González E
Front Cell Infect Microbiol; 2022; 12():884365. PubMed ID: 35669117
[TBL] [Abstract][Full Text] [Related]
38. Broad-specificity efflux pumps and their role in multidrug resistance of Gram-negative bacteria.
Nikaido H; Pagès JM
FEMS Microbiol Rev; 2012 Mar; 36(2):340-63. PubMed ID: 21707670
[TBL] [Abstract][Full Text] [Related]
39. A Whole-Cell Screen Identifies Small Bioactives That Synergize with Polymyxin and Exhibit Antimicrobial Activities against Multidrug-Resistant Bacteria.
Zimmerman SM; Lafontaine AJ; Herrera CM; Mclean AB; Trent MS
Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844003
[TBL] [Abstract][Full Text] [Related]
40. In-vitro activity of tigecycline against multidrug-resistant Gram negative bacteria: The experience of a university hospital.
Elnasser Z; Elsamarneh R; Obeidat H; Amarin Z; Jaradat S; Kaplan N
J Infect Public Health; 2021 Apr; 14(4):478-483. PubMed ID: 33743369
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
